Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $28.65, with a market capitalization of 163.5B. The stock trades at a price-to-earnings (P/E) ratio of 37.62 and offers a dividend yield of 6.05%.
On 2026-09-26, Pfizer(PFE) stock traded between a low of $28.17 and a high of $28.69. Shares are currently priced at $28.65, which is +1.7% above the low and -0.1% below the high.
The Pfizer(PFE)'s current trading volume is 27.76M, compared to an average daily volume of 35.15M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.61.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.61.
PFE News
Key Points AbbVie is transitioning its revenue base toward newer immunology drugs to offset the decline of its legacy treatments. Pfizer is leaning on heavy i...
Pfizer (PFE) shares clocked seven straight sessions of gains, as the stock was up 1% at $28.68 on Friday. The global biopharmaceutical company gained 2.8% in t...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is launching a new study to test ponsegromab in adults with non-small c...
Analyst ratings
61%
of 28 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a phase 3 study called “A Study to Learn About Revaccination...
Key Points Bristol Myers Squibb maintains strong positions in oncology and neuroscience with high free cash flow generation. Pfizer is undergoing a major tran...
BridgeBio Pharma (BBIO) on Wednesday announced that its heart disease therapy acoramidis, branded as Attruby in the U.S., outperformed Pfizer’s (PFE) rival drug...
has delivered a 1 year gain that may catch the eye of investors who remember how volatile large drug makers can be, and the question now is whether the current...
Picking a solid dividend stock to own for the long haul isn't necessarily easy. Balancing safety and dividend income can make it challenging to find the right s...
Pfizer (PFE) CEO Albert Bourla is expected to attend President Trump’s September 24 state dinner for Chinese President Xi Jinping, as the leaders seek greater s...
Key Points Dividend payments offer you security in difficult markets -- and extra growth in better times. These pharma companies offer dividend yields that be...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.